Pyrazinamide 750 mg Tablet PCD Franchise in Mumbai

Anti-TB Medicine Supplier in Delhi NCR

Tuberculosis Treatment Tablet Distributor in Chennai

Anti-Infective Pharma Franchise in Kolkata

Pyrazinamide 750 mg Tablet Stockist in Bangalore
TB Drug Export & Manufacturing in Hyderabad

Home/Products /pyrazinamide-ip-750-mg-tablet

About the Product

Description


Pyrinide 750 Tablet contains Pyrazinamide 750 mg, a first-line anti-tubercular medicine used in combination therapy to treat active tuberculosis. It works by inhibiting the synthesis of mycobacterial cell wall fatty acids, helping to stop bacterial replication.

This higher-dose formulation is commonly prescribed during the intensive phase of TB therapy, usually alongside Isoniazid, Rifampicin, and Ethambutol, ensuring effective bacterial clearance and improved treatment outcomes.

Belonging to the anti-infective and pulmonology segment, Pyrinide 750 Tablet is in consistent demand among hospitals, TB clinics, and government healthcare programs. Its essential role in standard TB regimens guarantees recurring market need.

For PCD pharma franchise partners, third-party manufacturers, and exporters, Pyrinide 750 Tablet provides a profitable B2B opportunity. Its high demand in TB treatment programs makes it a stable and rewarding product for pharma businesses across India.

Common side effects include nausea, vomiting, loss of appetite, and mild joint pain. Rarely, it may lead to liver toxicity, hyperuricemia (gout), or allergic reactions. Seek medical attention immediately if you experience jaundice, severe fatigue, or swelling.

Pyrinide 750 Tablet is indicated for the treatment of active tuberculosis, usually alongside other first-line anti-TB drugs such as Isoniazid and Rifampicin. It aids in reducing bacterial load and preventing disease progression and transmission.

Take Pyrinide 750 Tablet exactly as prescribed, preferably on an empty stomach. Avoid alcohol during therapy due to the risk of liver damage. Regular monitoring of liver function and uric acid levels is advised. Do not discontinue the medication without consulting your healthcare provider.

Store Pyrinide 750 Tablet in a cool, dry place below 25°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Pyrazinamide IP 750mg Tablet in the PCD pharma franchise market?

Pyrazinamide IP 750mg Tablet has consistent demand in the anti-infective, respiratory care, and tuberculosis (TB) management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on specialty infectious disease portfolios.

Why should medical distributors include Pyrazinamide IP 750mg Tablet in their product range?

Medical distributors and agencies can benefit from demand for tuberculosis management under specialist medical supervision. Pyrazinamide IP 750mg is an antitubercular medication used as part of combination therapy for tuberculosis treatment Commonly prescribed for the management of active tuberculosis (TB) as advised by healthcare professionals and national treatment guidelines Plays an important role in multidrug anti-tuberculosis treatment regimens, helping improve treatment effectiveness and reduce treatment duration when used appropriately Higher-strength formulation supports individualized dosing requirements in TB management programs Oral tablet formulation offers convenient administration as part of prescribed combination therapy Requires regular monitoring of liver function and overall treatment response during therapy Frequently utilized in chest clinics, pulmonary care centers, hospitals, TB treatment programs, and infectious disease departments Widely prescribed by pulmonologists, infectious disease specialists, and general physicians involved in tuberculosis care This strengthens a comprehensive anti-infective and tuberculosis care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pyrazinamide IP 750mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent institutional demand, government and private healthcare procurement opportunities, reliable supply chain support, repeat purchases, and attractive margins in the anti-infective segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.